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Tuberculosis (TB), as the major infectious disease in the world, has devastating
consequences for not only humans, but also cattle and several wildlife species. This
disease presents additional challenges to human and veterinary health authorities given
the zoonotic nature of the pathogens responsible for the disease across species. One of
the main public health challenges regarding zoonotic TB (ZTB) caused byMycobacterium
bovis is that the true incidence of this type of TB in humans is not known and is likely
to be underestimated. To effectively address challenges posed by ZTB, an integrated
One Health approach is needed. In this manuscript, we describe the rationale, major
steps, timeline, stakeholders, and important events that led to the assembling of a true
integrated multi-institutional and interdisciplinary team that accomplished the ambitious
goal of developing a ZTB roadmap, published in October, 2017. It outlines key activities
to address the global challenges regarding the prevention, surveillance, diagnosis, and
treatment of ZTB. We discuss and emphasize the importance of integrated approaches
to be able to accomplish the short (year 2020) and medium term (year 2025) goals
outlined in the ZTB roadmap.
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INTRODUCTION
Worldwide, there is consensus that solutions to complex issues need the participation and
involvement of different stakeholders. Recent outbreaks of emerging and re-emerging zoonoses
[i.e., Zika, Ebola, Middle East Respiratory Syndrome (MERS), Avian and Swine Influenza] (1)
have heightened the public’s awareness about the close and complex interrelationship between the
health of humans, wildlife species, and domestic animals. Tuberculosis (TB), is one such disease
that continues to have devastating consequences for not only humans, but also cattle and several
wildlife species (2–5). Caused by bacteria belonging to the Mycobacterium tuberculosis complex
(MTBC), TB presents additional challenges to human and veterinary health authorities given the
zoonotic nature of the pathogens responsible for the disease and the ability of MTBC agents to
be shared across species (4, 5). TB in humans is caused primarily by Mycobacterium tuberculosis
(M. tb); worldwide, it is the leading cause of death in humans by an infectious disease (2). Bovine
TB caused by Mycobacterium bovis (M. bovis) is widely distributed around the world (3, 6) and
continues to cause considerable economic losses to farmers and countries due to the reduced
production of affected animals, culling of animals from herds (or entire herd depopulation in
some cases), and the elimination of affected (or all) parts of animal carcasses at slaughter (7).
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M. bovis can also infect and cause TB in humans (zoonotic
tuberculosis (ZTB) (8–11). The World Health Organization
(WHO) estimated that “in 2016 there were 147,000 new cases of
ZTB and 12,500 deaths due to this type of TB” (2). Furthermore,
M. bovis has the ability to cause TB and cause death in several
wildlife species (4, 5).
One of the main public health challenges regarding ZTB is
that its true incidence in humans is not known and is likely to
be underestimated due to the lack of systematic surveillance for
M. bovis as a causal agent of TB in people in all low-income,
high TB burden countries where bovine TB is endemic, and
the inability of laboratory procedures most commonly used to
diagnose human TB to identify and differentiate M. bovis from
M. tb (12). To effectively address challenges posed by ZTB
(and other diseases at the “animal-human” interface), a cross-
sectorial and multidisciplinary One Health approach linking
animal, human, and environmental health is required.
In this manuscript, we describe the rationale, major steps,
timeline, stakeholders, and important events that lead to
the assembling of a true integrated multi-institutional and
interdisciplinary team that worked toward and accomplished the
ambitious goal of developing a ZTB roadmap that was published
in English, Spanish, and French (13–15) to address the global
challenges regarding the prevention, surveillance, diagnosis, and
treatment of zoonotic TB (ZTB), globally. We discuss and
emphasize the importance of integrated approaches to be able to
accomplish the short (year 2020) and medium term (year 2025)
goals outlined in the ZTB roadmap.
A Robust Interdisciplinary Platform
The International Union Against Tuberculosis and Lung Disease
(The Union) is an international scientific organization that
works with partners, including governments, academia, and civil
society, to fight TB, tobacco use and other lung diseases in
low- and middle-income countries, through technical assistance,
training, and research. Through its volunteer members, it houses
scientific sections that promote areas of specific interest. The
Union’s ZTB sub-section is a global network of physicians,
veterinarians, researchers, economists and social anthropologists
that works to understand the dynamics of ZTB, create global
awareness, and facilitate multi-institutional collaboration to
address the challenges posed by it. Efforts conducted by the
ZTB sub-section has led to a continuous and stable increase in
the number of activities, attention, and attendees to ZTB-related
activities at the annual UnionWorld Conference on LungHealth.
For example, at the 2010 conference in Berlin, Germany, there
was only one ZTB session (symposium) attended by less than 10
people. Over the last seven years, the ZTB activities at the annual
conference have increased to two scientific symposia, one poster
session, one meet the expert session, press releases, and a keynote
talk on ZTB at the plenary session in South Africa during the 2015
conference. During the last conference in Guadalajara, Mexico
in October 2017, an audience of approximately 75 professionals
from different disciplines attended each of the two ZTB scientific
symposia.
Prior to The Union’s initial activities to create global
awareness of ZTB, in 2010, the WHO, OIE and FAO pioneered
One Health approaches under a tripartite partnership, which
shares responsibilities and jointly develop and implement
integrated strategies for addressing health risks at the human
animal-ecosystem interface (12). The combined involvement
and commitment of these three institutions has been crucial
to successfully develop a ZTB roadmap since these institutions
jointly: (1) provide global leadership for TB prevention, care and
control (WHO); (2) is responsible for improving animal health
and welfare (OIE); and (3) work toward improving food security,
nutrition and agricultural productivity and reduce rural poverty
(FAO).
Initial Efforts to Develop a ZTB Roadmap
In March 2014, the ZTB sub-section created a working group
to raise awareness of the public health risk posed by ZTB. This
working group included participants from key parties including
the:
- College of Veterinary Medicine and Biomedical Sciences,
Colorado State University, United States of America
- Food and Agriculture Organization (FAO) of the United
Nations with its Animal Production and Health Division
- International Union Against Tuberculosis and Lung Disease
(The Union).
- Pan-American Foot-and-Mouth Disease Center
(PANAFTOSA) from the Pan American Health
Organization/Regional Office for the Americas of the
World Health Organization
- Roslin Institute, Royal (Dick) School of Veterinary Studies,
University of Edinburgh
- STOP TB Partnership
- United States Centers for Disease Control and Prevention
(CDC)
- United States Department of Agriculture, Animal and Plant
Health Inspection Service,
- World Health Organization (WHO) with its
• Global TB Programme, and
• The Department of Global Capacities, Alert, and Response
- World Organization for Animal Health (OIE)
One of the accomplishments of this working group was the
publication of a manuscript (10) calling for a call to action in the
Lancet Infectious Disease Journal.
A constellation of events has occurred to bring ZTB to the
awareness of scientists, policymakers, government officials and
the general public.
May 2014: The End TB Strategy
In May 2014, the World Health Assembly, WHO’s yearly
gathering of the world’s Ministers of Health, approved the new
post-2015 Global TB Strategy. The strategy aims to end, rather
than merely control, the global TB epidemic, with targets to
reduce TB deaths by 95% and to reduce new cases by 90%
between 2015 and 2035, and to ensure that no family is burdened
with catastrophic expenses due to TB. It set interim milestones
for 2020, 2025, and 2030 (16). Thus, finding and treating every
case of TB, whether caused by M. tb or M. bovis, will count
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toward the achievement of this ambitious goal. For this reason,
as countries move toward detecting the 3 million TB cases
estimated to be missed annually, and in light of the endorsed
WHO “END TB” strategy, the Tripartite, The Union and the
key organizations concerned with human and animal health,
agriculture and TB joined forces to develop a Zoonotic TB Road
Map outlining medium- and long-term milestones to globally
address the prevention, surveillance, diagnostic, and treatment
challenges faced by persons with ZTB.
Sept 2015
In September 2015, the United Nations declared the end of the
MillenniumDevelopment Goals and used them as the foundation
for the Sustainable Development Goals (SDGs) (17) for 2015–
2030, encompassing 17 broad and comprehensive topic areas,
ranging from elimination of poverty and hunger, improved
education and gender equality, to clean water and energy, action
on climate and improvement of life under water and on land. The
third SDG addresses global health, with TB highlighted as one of
the priorities, thus presenting a key opportunity to improve the
health of communities affected by ZTB.
Nov 2015
The Stop TB Partnership, the global advocacy organization for
TB, published the 4th edition of its Global Plan to End TB, 2016–
2020 entitled “The paradigm shift” (18). This is a costed plan that
includes actions needed to decrease TB, and is in full support of
WHO’s End TB Strategy. The Global Plan has set its 90-(90)-90
targets, which are to: identify 90% of all TB cases; concentrate
on identifying 90% of those in key populations; and ensure 90%
obtain appropriate treatment until cure. For the first time in this
document, communities and people at risk of contracting ZTB
were included as a key population.
April 2016
A meeting co-organized by WHO and The Union, with
contributions from leading international organizations for
human and animal health, academic institutions, and non-
governmental organizations took place at WHO in Geneva.
There, the first steps toward formally conceptualizing a roadmap
for ZTB began, in which ten priorities were identified to be
presented to WHO’s Global TB Programme’s Strategic Technical
Advisory Group (STAG) for TB in June 2016. In addition to the
10 institutions initially working on increasing global awareness of
ZTB, the following institutions joined the efforts at this specific
meeting:
- Swiss Tropical and Public Health Institute, Switzerland
- Animal and Plant Health Agency (APHA), United Kingdom
- University of Ibadan, Nigeria
- The Global Research Alliance for bovine Tuberculosis
(GRAbTB)
The involvement and participation of GRAbTB was an
important addition and played a strategic role in partnering
with colleagues focusing in improve the understanding and
control of bovine TB and developing novel and improved tools
to control the disease at its bovine source (13). GRAbTB was
established in 2014 and as part of its strategic goals, the alliance
seeks not only to enhance collaboration within its members and
institutions, but also with the broader human and animal TB
research community.
June 2016
The 10 priorities proposed for the ZTB roadmap were endorsed
by the STAG, and a working group was created and tasked to
produce and publish a ZTB Road Map during 2017.
ZTB Patient Testimonies
At the STAG meeting, a former ZTB survivor, from the Masaai
community in Kenya shared with the scientific community the
challenges she faced while suffering from this disease, which
included: initial misdiagnosis, development of extrapulmonary
(abdominal) TB, antimicrobial resistance to anti-TB drugs
additional to the inherent resistance M. bovis has against
pyrazinamide, and the need for longer (12 months) antimicrobial
treatment, compared to the standard of 6 months.
During the 47th Union World Conference on Lung Health
in Liverpool, England, a British veterinarian and former ZTB
patient/survivor also shared his experience and challenges
of initial misdiagnosis, extrapulmonary (pleural) TB, drug
resistance to isoniazid in addition to pyrazinamide, and the
longer treatment required while battling ZTB in the year 2013.
These patients’ testimonies further emphasized that ZTB is
not a disease from the past, and highlighted the challenges faced
by certain communities at higher risk of contracting ZTB. Both
patients emphasized the need of more awareness among the
medical community to better diagnose and treat ZTB patients,
and thus prevent the additional complications they had to
endure.
July 2017
The Heads of State comprising the G20 forum declared that
“Shaping an interconnected world, calls for a One Health
approach to tackling the spread of antimicrobial resistance and
highlighted the need to foster research and development for
TB” (19).
October 2017
The Roadmap for ZTB was published and launched at the Union
World Conference for Lung Health in Guadalajara, Mexico. The
roadmap is the product of efforts of the tripartite partnership
on Zoonotic Diseases comprising WHO, OIE, and FAO and The
Union, and is available in English, French, and Spanish (13).
The Role of Media
over the past 3 years, all efforts, activities, and events related
to ZTB were highlighted by a considerable number of local,
regional, national, and global media sources including Central
News Network (CNN), the British Broadcasting Corporation
(BBC), and Le Monde newspaper in France, to name a few.
The Zoonotic TB Roadmap (13) outlines 10 priorities to
address the existing challenges posed by ZTB, divided into
three major core themes: (1) Improve the scientific evidence,
(2) Reduce transmission at the animal-human interface, and
(3) Strengthen intersectoral and collaborative approaches.
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BOX 1 | Zoonotic TB Roadmap (13) point 9
“Identify opportunities for community-tailored interventions that jointly address human and animal health Interventions that jointly address human and animal health
can increase health and economic benefits for communities. Sharing of human resources, equipment and transport across sectors can reduce operational costs.
This increased cost-effectiveness is especially relevant given the public funding constraints that often exist in settings where people are most at risk of zoonotic TB.
For example, outreach childhood immunization campaigns or other existing livestock vaccination or testing programmes conducted in rural communities could be
used to concurrently deliver educational and behavior change messages about food safety, to test livestock for bovine TB or, potentially in the future, to implement
livestock vaccination campaigns against bovine TB. Interventions must be tailored to the cultural and socioeconomic characteristics of each setting. Community-driven
participatory initiatives are key to achieving sustainability.”
TABLE 1 | Timeline for action and milestones to be achieved in the short (2020) and medium term (2025) outlines in the ZTB Roadmap (13).




MILESTONES TO BE ACHIEVED BY YEAR 2020
Joint guidance developed for surveillance and
management of zoonotic and bovine TB, at global
and national levels
Capacity of national veterinary services
strengthened for improving animal health, including
detecting and controlling bovine TB in livestock and
wildlife
Zoonotic and bovine TB properly
addressed by government authorities and
other stakeholders, in light of available
evidence
Improved detection, recording and reporting of
zoonotic and bovine TB within countries to allow
more accurate estimations of disease burden
Efforts scaled-up to improve national food safety
standards
Intersectoral and multidisciplinary
collaborations established to build
mechanisms and policies for One Health
coordination and communication, within
and between countries
Capacity of national healthcare and laboratory
services strengthened for diagnosing and treating
zoonotic TB
Community education campaigns implemented
nationally to raise awareness of foodborne diseases
and promote behavioral change
Global case for investment and business
plan developed, providing rationale for
investing in zoonotic and bovine TB and
detailing the activities and resources
needed
Targeted surveys conducted to identify high-risk
populations
Global advocacy strengthened to promote
a research agenda that addresses
knowledge gaps
MILESTONES TO BE ACHIEVED BY YEAR 2025
New, rapid diagnostic tools available for diagnosing
zoonotic TB and rolled-out to high risk groups
New diagnostics assays available for livestock Mainstreaming of One Health approaches
into efforts to improve human and animal
health at global, national and community
levels
Appropriate drug regimens defined for effective
treatment of zoonotic TB
Effective bovine TB vaccines available for livestock
and rolled-out in endemic settings
Anti-TB vaccine available for people and rolled-out Multi-species transmission pathways and sources
of infection better characterized and used to inform
the design of appropriate interventions
Point 9 in the roadmap under core theme 3 specifically
highlights the need of implementing integrated approaches
to disease monitoring linking animal and public health
(Box 1).
Moving Forward
Although the publication of the ZTB Roadmap represents an
unprecedented and historical accomplishment in the fight against
global TB (20), there is still much work to be conducted in order
to implement the actions needed to improve the prevention,
diagnosis, control and treatment of ZTB. Table 1 is an excerpt
from the ZTB Roadmap in which the short (year 2020) and
medium term (year 2025) milestones to be accomplished are
outlined under the three core themes of the roadmap. One
of the key elements toward accomplishing these goals is that
the unique cultural and socioeconomic factors that shape the
relationship between people, livestock, and wildlife species in
different ecosystems must be taken into account, while including
the at- risk communities in future efforts to reduce the risk
of zoonotic transmission of M. bovis across species. These
efforts not only need to focus on preventing transmission from
livestock (mostly cattle) to humans, but also, and in parallel,
to reduce the prevalence of the disease in both domestic and
wildlife species. The availability of improved diagnostic tools
for ZTB in different species, as well as the implementation
of disease monitoring, surveillance, and prevention strategies
in livestock and wildlife species will be a crucial and much
needed component to be able to implement comprehensive
programs that will account for the complexities ZTB poses due
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to its zoonotic nature. Finally, including vaccination of wildlife
(where feasible), not only has the potential for reducing the
burden of disease, but also could play an important role in
conservation efforts, especially among endangered and protected
species.
CONCLUSION
Implementing an integrated approach to develop the ZTB
road map did not come without the inherent challenges of
multidisciplinary and multi-institutional projects. That said, the
accomplishment of this milestone in the fight against TB was the
vision of a world free of TB, no matter what its source, the strong
support of WHO and the Stop TB Partnership, a motivated
core group that drove the process by providing clear goals and
timelines, being inclusive by inviting all interested parties, and
fostering a strong commitment to work together from colleagues
and institutions both from the human and animal sectors that
previously were working in isolation. This collaboration has
opened new doors and opportunities as the world fights to
end TB.
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